Abstract
Background
Lamin A/C alternative splice variants (Lamin A, Lamin C, Lamin AΔ10 and Lamin AΔ50) have been implicated in cell cycle regulation, DNA replication, transcription regulation, cellular differentiation, apoptosis and aging. In addition, loss of Lamin A/C expression has been observed in several cancers, including breast cancer, and it has been found that Lamin A/C suppression may lead to cancer-like aberrations in nuclear morphology and aneuploidy. Based on these observations, we hypothesized that Lamin A/C transcript variant quantification might be employed for the diagnosis of breast cancer.
Methods
Newly designed TaqMan qRT-PCR assays for the analysis of Lamin A/C splice variants were validated and their use as biomarkers for the diagnosis of breast cancer was assessed using 16 normal breast tissues and 128 breast adenocarcinomas. In addition, the expression levels of the Lamin A/C transcript variants were measured in samples derived from seven other types of cancer.
Results
We found that the expression level of Lamin C was significantly increased in the breast tumors tested, whereas the expression levels of Lamin A and Lamin AΔ50 were significantly decreased. No significant change in Lamin AΔ10 expression was observed. Our data also indicated that the Lamin C : Lamin A mRNA ratio was increased in all clinical stages of breast cancer. Additionally, we observed increased Lamin C : Lamin A mRNA ratios in liver, lung and thyroid carcinomas and in colon, ovary and prostate adenocarcinomas.
Conclusions
From our data we conclude that the Lamin C : Lamin A mRNA ratio is increased in breast cancer and that this mRNA ratio may be of diagnostic use in all clinical stages of breast cancer and, possibly, also in liver, lung, thyroid, colon, ovary and prostate cancers.
Similar content being viewed by others
References
J.L. Broers, B.M. Machiels, G.J. van Eys, H.J. Kuijpers, E.M. Manders, R. van Driel, F.C. Ramaekers, Dynamics of the nuclear lamina as monitored by GFP-tagged A-type lamins. J. Cell Sci. 112(Pt 20), 3463–3475 (1999)
A. Taddei, F. Hediger, F.R. Neumann, S.M. Gasser, The function of nuclear architecture: a genetic approach. Annu. Rev. Genet. 38, 305–345 (2004)
T. Shimi, R.D. Goldman, Nuclear lamins and oxidative stress in cell proliferation and longevity. Adv. Exp. Med. Biol. 773, 415–430 (2014)
H. Cao, R.A. Hegele, LMNA is mutated in Hutchinson-Gilford progeria (MIM 176670) but not in Wiedemann-Rautenstrauch progeroid syndrome (MIM 264090). J. Hum. Genet. 48, 271–274 (2003)
A. De Sandre-Giovannoli, R. Bernard, P. Cau, C. Navarro, J. Amiel, I. Boccaccio, S. Lyonnet, C.L. Stewart, A. Munnich, M. Le Merrer, N. Levy, Lamin a truncation in Hutchinson-Gilford progeria. Science 300, 2055 (2003)
M. Eriksson, W.T. Brown, L.B. Gordon, M.W. Glynn, J. Singer, L. Scott, M.R. Erdos, C.M. Robbins, T.Y. Moses, P. Berglund, A. Dutra, E. Pak, S. Durkin, A.B. Csoka, M. Boehnke, T.W. Glover, F.S. Collins, Recurrent de novo point mutations in lamin A cause Hutchinson-Gilford progeria syndrome. Nature 423, 293–298 (2003)
B.M. Machiels, A.H. Zorenc, J.M. Endert, H.J. Kuijpers, G.J. van Eys, F.C. Ramaekers, J.L. Broers, An alternative splicing product of the lamin A/C gene lacks exon 10. J. Biol. Chem. 271, 9249–9253 (1996)
L. Mounkes, S. Kozlov, B. Burke, C.L. Stewart, The laminopathies: nuclear structure meets disease. Curr. Opin. Genet. Dev. 13, 223–230 (2003)
A. Muchir, H.J. Worman, The nuclear envelope and human disease. Physiology (Bethesda) 19, 309–314 (2004)
D. McClintock, D. Ratner, M. Lokuge, D.M. Owens, L.B. Gordon, F.S. Collins, K. Djabali, The mutant form of lamin A that causes Hutchinson-Gilford progeria is a biomarker of cellular aging in human skin. PLoS One 2, e1269 (2007)
B.C. Capell, F.S. Collins, Human laminopathies: nuclei gone genetically awry. Nat. Rev. Genet. 7, 940–952 (2006)
N. Sylvius, F. Tesson, Lamin A/C and cardiac diseases. Curr. Opin. Cardiol. 21, 159–165 (2006)
C.D. Capo-chichi, K.Q. Cai, J. Smedberg, P. Ganjei-Azar, A.K. Godwin, X.X. Xu, Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer. Chin. J. Cancer 30, 415–425 (2011)
B.M. Machiels, J.L. Broers, Y. Raymond, L. de Ley, H.J. Kuijpers, N.E. Caberg, F.C. Ramaekers, Abnormal A-type lamin organization in a human lung carcinoma cell line. Eur. J. Cell Biol. 67, 328–335 (1995)
C.D. Capo-chichi, B. Aguida, N.W. Chabi, Q.K. Cai, G. Offrin, V.K. Agossou, A. Sanni, X.-X. Xu, Lamin A/C deficiency is an independent risk factor for cervical cancer. Cell. Oncol. (2015). doi:10.1007/s13402-015-0252-6
B. Stadelmann, E. Khandjian, A. Hirt, A. Luthy, R. Weil, H.P. Wagner, Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin’s lymphoma cells. Leuk. Res. 14, 815–821 (1990)
R. Agrelo, F. Setien, J. Espada, M.J. Artiga, M. Rodriguez, A. Perez-Rosado, A. Sanchez-Aguilera, M.F. Fraga, M.A. Piris, M. Esteller, Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. J. Clin. Oncol. 23, 3940–3947 (2005)
J.D. Debes, T.J. Sebo, H.V. Heemers, B.R. Kipp, D.L. Haugen, C.M. Lohse, D.J. Tindall, p300 modulates nuclear morphology in prostate cancer. Cancer Res. 65, 708–712 (2005)
L. Kong, G. Schafer, H. Bu, Y. Zhang, H. Klocker, Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway. Carcinogenesis 33, 751–759 (2012)
N.D. Willis, T.R. Cox, S.F. Rahman-Casans, K. Smits, S.A. Przyborski, P. van den Brandt, M. van Engeland, M. Weijenberg, R.G. Wilson, A. de Bruine, C.J. Hutchison, Lamin A/C is a risk biomarker in colorectal cancer. PLoS One 3, e2988 (2008)
N.D. Willis, R.G. Wilson, C.J. Hutchison, Lamin A: a putative colonic epithelial stem cell biomarker which identifies colorectal tumours with a more aggressive phenotype. Biochem. Soc. Trans. 36, 1350–1353 (2008)
E.J. Belt, R.J. Fijneman, E.G. van den Berg, H. Bril, P.M. Delis-van Diemen, M. Tijssen, H.F. van Essen, E.S. de Lange-de Klerk, J.A. Belien, H.B. Stockmann, S. Meijer, G.A. Meijer, Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence. Eur. J. Cancer 47, 1837–1845 (2011)
P. Scaffidi, T. Misteli, Reversal of the cellular phenotype in the premature aging disease Hutchinson-Gilford progeria syndrome. Nat. Med. 11, 440–445 (2005)
S. Rodriguez, F. Coppede, H. Sagelius, M. Eriksson, Increased expression of the Hutchinson-Gilford progeria syndrome truncated lamin A transcript during cell aging. Eur. J. Hum. Genet. 17, 928–937 (2009)
J.I. Toth, S.H. Yang, X. Qiao, A.P. Beigneux, M.H. Gelb, C.L. Moulson, J.H. Miner, S.G. Young, L.G. Fong, Blocking protein farnesyltransferase improves nuclear shape in fibroblasts from humans with progeroid syndromes. Proc. Natl. Acad. Sci. U. S. A. 102, 12873–12878 (2005)
C.L. Moulson, L.G. Fong, J.M. Gardner, E.A. Farber, G. Go, A. Passariello, D.K. Grange, S.G. Young, J.H. Miner, Increased progerin expression associated with unusual LMNA mutations causes severe progeroid syndromes. Hum. Mutat. 28, 882–889 (2007)
R. Al-Saaidi, P. Bross, Do lamin A and lamin C have unique roles? Chromosoma 124, 1–12 (2015)
I.C. Lopez-Mejia, M. de Toledo, C. Chavey, L. Lapasset, P. Cavelier, C. Lopez-Herrera, K. Chebli, P. Fort, G. Beranger, L. Fajas, E.Z. Amri, F. Casas, J. Tazi, Antagonistic functions of LMNA isoforms in energy expenditure and lifespan. EMBO Rep. 15, 529–539 (2014)
J.L. Broers, B.M. Machiels, H.J. Kuijpers, F. Smedts, R. van den Kieboom, Y. Raymond, F.C. Ramaekers, A- and B-type lamins are differentially expressed in normal human tissues. Histochem. Cell Biol. 107, 505–517 (1997)
M.A. Eckersley-Maslin, J.H. Bergmann, Z. Lazar, D.L. Spector, Lamin A/C is expressed in pluripotent mouse embryonic stem cells. Nucleus 4, 53–60 (2013)
R.A. Rober, K. Weber, M. Osborn, Differential timing of nuclear lamin A/C expression in the various organs of the mouse embryo and the young animal: a developmental study. Development 105, 365–378 (1989)
J. Swift, I.L. Ivanovska, A. Buxboim, T. Harada, P.C. Dingal, J. Pinter, J.D. Pajerowski, K.R. Spinler, J.W. Shin, M. Tewari, F. Rehfeldt, D.W. Speicher, D.E. Discher, Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation. Science 341, 1240104 (2013)
H.J. Jung, J.M. Lee, S.H. Yang, S.G. Young, L.G. Fong, Nuclear lamins in the brain - new insights into function and regulation. Mol. Neurobiol. 47, 290–301 (2013)
T. Wakabayashi, T. Mori, Y. Hirahara, T. Koike, Y. Kubota, Y. Takamori, H. Yamada, Nuclear lamins are differentially expressed in retinal neurons of the adult rat retina. Histochem. Cell Biol. 136, 427–436 (2011)
C.J. Hutchison, H.J. Worman, A-type lamins: guardians of the soma? Nat. Cell Biol. 6, 1062–1067 (2004)
F. Lin, H.J. Worman, Expression of nuclear lamins in human tissues and cancer cell lines and transcription from the promoters of the lamin A/C and B1 genes. Exp. Cell Res. 236, 378–384 (1997)
A. Matsumoto, M. Hieda, Y. Yokoyama, Y. Nishioka, K. Yoshidome, M. Tsujimoto, N. Matsuura, Global loss of a nuclear lamina component, lamin A/C, and LINC complex components SUN1, SUN2, and nesprin-2 in breast cancer. Canc. Med. 4, 1547–1557 (2015)
U. Wazir, M.H. Ahmed, J.M. Bridger, A. Harvey, W.G. Jiang, A.K. Sharma, K. Mokbel, The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer. Cell. Mol. Biol. Lett. 18, 595–611 (2013)
W.S. Lee, J.J. Jung, H.C. Jeung, S.W. Noh, B.K. Oh, K.Y. Kim, T.S. Kim, H.C. Chung, J.K. Roh, S.Y. Rha, Methylation status of lamin A/C in gastric cancer cell lines. Hepatogastroenterology 59, 1313–1318 (2012)
D. Constantinescu, H.L. Gray, P.J. Sammak, G.P. Schatten, A.B. Csoka, Lamin A/C expression is a marker of mouse and human embryonic stem cell differentiation. Stem Cells 24, 177–185 (2006)
D. Lourim, J.J. Lin, Expression of nuclear lamin A and muscle-specific proteins in differentiating muscle cells in ovo and in vitro. J. Cell Biol. 109, 495–504 (1989)
B. Liu, J. Wang, K.M. Chan, W.M. Tjia, W. Deng, X. Guan, J.D. Huang, K.M. Li, P.Y. Chau, D.J. Chen, D. Pei, A.M. Pendas, J. Cadinanos, C. Lopez-Otin, H.F. Tse, C. Hutchison, J. Chen, Y. Cao, K.S. Cheah, K. Tryggvason, Z. Zhou, Genomic instability in laminopathy-based premature aging. Nat. Med. 11, 780–785 (2005)
A. Peter, R. Stick, Evolution of the lamin protein family: what introns can tell. Nucleus 3, 44–59 (2012)
Y.S. Oh, D.G. Kim, G. Kim, E.C. Choi, B.K. Kennedy, Y. Suh, B.J. Park, S. Kim, Downregulation of lamin A by tumor suppressor AIMP3/p18 leads to a progeroid phenotype in mice. Aging Cell 9, 810–822 (2010)
Acknowledgments
This work was supported by the King Abdullah International Medical Research Center (KAIMRC) and National Guard Health Affairs, and conducted at the College of Medicine, King Saud bin Abdulaziz University for Health Sciences, Riyadh, Kingdom of Saudi Arabia.
Author’s contributions
AA and AS conceived the experimental design. AJ and AS supervised the project. HS, JD, AB, SM and AG designed and performed the experiments and AJ, AA and JD analyzed the data and wrote the paper.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors have no conflict of interest to declare.
Rights and permissions
About this article
Cite this article
Aljada, A., Doria, J., Saleh, A.M. et al. Altered Lamin A/C splice variant expression as a possible diagnostic marker in breast cancer. Cell Oncol. 39, 161–174 (2016). https://doi.org/10.1007/s13402-015-0265-1
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13402-015-0265-1